The cardiac ryanodine receptor (RyR2), but not sarcoplasmic reticulum Ca2+-ATPase, is a major determinant of Ca2+ alternans in intact mouse hearts and an important therapeutic target.
Is the cardiac ryanodine receptor or sarcoplasmic reticulum Ca2+-ATPase a major determinant of Ca2+ alternans in intact mouse hearts?
RyR2 is identified as a major determinant of Ca2+ alternans in intact mouse hearts, highlighting it as an important therapeutic target.
Tasa de eventos absoluta: 0% vs 0%
alternans in intact working hearts, making RyR2 an important therapeutic target for cardiac alternans.
Sun et al. (Mon,) reported a other. The cardiac ryanodine receptor (RyR2), but not sarcoplasmic reticulum Ca2+-ATPase, is a major determinant of Ca2+ alternans in intact mouse hearts and an important therapeutic target.